Skip to content

Assess the use of Gum-paint and Tablets applied over gums along with Cleaning in Diabetic patients with Gum Disease.

Evaluation of Efficacy of G32TM Gum paint and G32TM Tablets as an adjunct to Scaling in Diabetic patients with Chronic Periodontitis.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012726
Enrollment
60
Registered
2018-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetic patients with Chronic Periodontitis

Interventions

Intervention1: Use of G32 Gum paint and tablets in Diabetic patients with Chronic Periodontitis: It is an adjunctive aid used along with Scaling twice daily for first 15 days followed by once daily fo

Sponsors

Alarsin Pharmaceuticals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 25-70 years. 2. Patients with controlled diabetes (on oral hypoglycemic drugs) with glycosylated haemoglobin (HbA1c) levels 3. Patients with chronic periodontitis having periodontal pocket depth less than 4mm 4. Patients with minimum of 20 teeth. 5. Patients who have not received any type of periodontal therapy for the past 6 months

Exclusion criteria

Exclusion criteria: 1. Patients on insulin therapy 2. Patients suffering from any other systemic disease or with compromised immune system. 3. Patients with a known history of drug allergy 4. Patients taking any drug known to cause gingival enlargement 5. Patients taking any immuno-suppressive drugs like corticosteroids. 6. Pregnant and/or lactating mothers. 7. Patients with any bleeding disorders. 8. Patient on anticoagulant therapy. 9. Patients with smoking and tobacco chewing habits.

Design outcomes

Primary

MeasureTime frame
This study will help to evaluate an adjunct to scaling in Diabetic patients with Chronic Periodontitis for control or regression of gingival inflammation.Timepoint: Baseline and 1 month follow up

Secondary

MeasureTime frame
Reduction of gingival, plaque scores, probing pocket depth and clinical attachment lossTimepoint: Baseline and 1 month follow up

Countries

India

Contacts

Public ContactDr Shraddha Kode

Nair Hospital Dental College

drpraneetakamble@gmail.com9820263468

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026